Rankings
▼
Calendar
ALKS Q4 2019 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena
ALKS
Alkermes plc
$5B
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$413M
+30.7% YoY
Gross Profit
$366M
88.7% margin
Operating Income
-$10M
-2.4% margin
Net Income
-$5M
-1.3% margin
EPS (Diluted)
$-0.03
QoQ Revenue Growth
+61.7%
Cash Flow
Operating Cash Flow
$42M
Free Cash Flow
$10M
Stock-Based Comp.
$21M
Balance Sheet
Total Assets
$1.8B
Total Liabilities
$720M
Stockholders' Equity
$1.1B
Cash & Equivalents
$204M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$413M
$316M
+30.7%
Gross Profit
$366M
$267M
+37.4%
Operating Income
-$10M
$20,000
-49770.0%
Net Income
-$5M
-$10M
+44.9%
Revenue Segments
License
$145M
90%
Research And Development
$11M
7%
License And Service
$5M
3%
← FY 2019
All Quarters
Q1 2020 →